Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Busulfan lung.

M Pearl

    American Journal of Diseases of Children (1960)
    |June 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Busulfan therapy for chronic myelogenous leukemia can cause fatal pulmonary fibrosis, known as "busulfan lung." This report details the first pediatric case in a 16-month-old infant, highlighting the drug

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Vestibular Implant Imaging.

    AJNR. American journal of neuroradiology·2020
    Same author

    Use of cannabinoids in cancer patients: A Society of Gynecologic Oncology (SGO) clinical practice statement.

    Gynecologic oncology·2020
    Same author

    Expression of inflammatory cytokines by adipose tissue from patients with endometrial cancer.

    European journal of gynaecological oncology·2012
    Same author

    Hormonal evidence supports the theory of selection in utero.

    American journal of human biology : the official journal of the Human Biology Council·2012
    Same author

    Intracranial dural arteriovenous fistulas: classification, imaging findings, and treatment.

    AJNR. American journal of neuroradiology·2012
    Same author

    Environment: globalization of conservation: a view from the south.

    Science (New York, N.Y.)·2007
    Same journal

    Nonsteroidal anti-inflammatory drugs and gastrointestinal injury in children.

    American journal of diseases of children (1960)·1993
    Same journal

    Picture of the month. Cutaneous leishmaniasis.

    American journal of diseases of children (1960)·1993
    Same journal

    Pathological case of the month. Wells' syndrome.

    American journal of diseases of children (1960)·1993
    Same journal

    Radiological case of the month. Proteus syndrome: benign angiolipomatous tumor with intraspinal extension.

    American journal of diseases of children (1960)·1993
    Same journal

    Applicability of the Greulich and Pyle skeletal age standards to black and white children of today.

    American journal of diseases of children (1960)·1993
    Same journal

    Maltreatment of children born to cocaine-dependent mothers.

    American journal of diseases of children (1960)·1993
    See all related articles

    Area of Science:

    • Pediatric Oncology
    • Pulmonary Medicine
    • Toxicology

    Background:

    • Busulfan is a chemotherapy agent used for chronic myelogenous leukemia.
    • Pulmonary fibrosis is a rare but lethal side effect of busulfan therapy.

    Observation:

    • A 16-month-old infant received busulfan for 11 months.
    • The infant developed progressive lung changes consistent with diffuse intra-alveolar and interstitial fibrosis.
    • The patient experienced acute respiratory distress and expired.

    Findings:

    • Histological examination revealed characteristic busulfan-induced lung and pancreatic changes.
    • Autopsy excluded infection or leukemic infiltration as causes of lung pathology.
    • This case represents the first reported instance of busulfan lung in a pediatric patient.

    Implications:

    • Highlights the potential for busulfan-induced pulmonary toxicity in pediatric patients.
    • Emphasizes the need for vigilant monitoring of lung function in children undergoing busulfan therapy.
    • Underscores the importance of considering drug-induced lung disease in pediatric respiratory failure.